Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease

被引:16
|
作者
Cai, Changzhou [1 ]
Song, Xin [1 ]
Yu, Chaohui [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Expression; bioinformatics; hepatocellular carcinoma; non-alcoholic fatty liver disease; CEP192; STEATOHEPATITIS; EPIDEMIOLOGY; BIOMARKERS; MICRORNAS; PATHWAY; CYCLE;
D O I
10.3233/CBM-190169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Hepatocellular carcinoma (HCC) is the leading cause of mortality worldwide. In recent years, the incidence of HCC induced by NAFLD is growing rapidly. OBJECTIVE: To screen for new pathogenic genes and related pathways both in NAFLD and HCC, and to explore the pathogenesis of progression from NAFLD to HCC. METHODS: Gene expression microarrays (GSE74656, GSE62232) were used for identifying differentially expressed genes (DEGs). Functional enrichment and pathway enrichment analyses indicated that these DEGs were related to cell cycle and extracellular exosome, which were closely related to NAFLD and HCC development. We then used the Search Tool for the Retrieval of Interacting Genes (STRING) to establish the protein-protein interaction (PPI) network and visualized them in Cytoscape. And the overall survival (OS) analysis and gene expression validation in TCGA of hub genes was performed. RESULTS: Seven hub genes, including CDK1, HSP90AA1, MAD2L1, PRKCD, ITGB3BP, CEP192, and RHOB were identified. Finally, we verified the expression level of ITGB3BP and CEP192 by quantitative real-time PCR in vitro. CONCLUSIONS: The present study implied possible DEGs, especially the new gene CEP192, in the progression of NAFLD developing to HCC. Further rigorous experiments are required to verify the above results.
引用
收藏
页码:69 / 78
页数:10
相关论文
共 50 条
  • [41] Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach
    Grgurevic, Ivica
    Bozin, Tonci
    Mikus, Mislav
    Kukla, Michal
    O'Beirne, James
    CANCERS, 2021, 13 (22)
  • [42] Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: From a Clinical to a Molecular Association
    Petta, S.
    Craxi, A.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (06) : 741 - 752
  • [43] Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
    Plaz Torres, Maria Corina
    Bodini, Giorgia
    Furnari, Manuele
    Marabotto, Elisa
    Zentilin, Patrizia
    Strazzabosco, Mario
    Giannini, Edoardo G.
    CANCERS, 2020, 12 (06)
  • [44] Hepatocellular carcinoma in young morbid obese patients with non-alcoholic fatty liver disease
    Tobari, Maki
    Hashimoto, Etsuko
    Taniai, Makiko
    Nishino, Takayoshi
    Tokushige, Katsutoshi
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2020, 13 (06) : 1289 - 1296
  • [45] Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease
    Nguyen, Nga
    Rode, Agnes
    Trillaud, Herve
    Aube, Christophe
    Manichon, Anne Frederique
    Hocquelet, Arnaud
    Paisant, Anita
    Dao, Thong
    Nahon, Pierre
    Ganne-Carrie, Nathalie
    Blaise, Lorraine
    Cauchy, Francois
    Sutter, Olivier
    Seror, Olivier
    Nault, Jean-Charles
    LIVER INTERNATIONAL, 2022, 42 (04) : 905 - 917
  • [46] Hepatocellular carcinoma can occur in non-alcoholic fatty liver disease without cirrhosis
    Leung, C.
    Yeoh, S.
    Patrick, D.
    Ket, S.
    Marion, K.
    Gow, P.
    Angus, P. W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 76 - 76
  • [47] CLINICAL PATTERNS OF HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC FATTY LIVER DISEASE AND HEPATITIS B
    Tay, Benjamin Wei Rong
    Huang, Daniel
    Tey, Yi Qing
    Mok, John
    Kow, Alfred
    Bonney, Glenn Kunnath
    Tan, Poh Seng
    Dan, Yock Young
    HEPATOLOGY, 2019, 70 : 531A - 531A
  • [48] Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
    Lampros Chrysavgis
    Ilias Giannakodimos
    Panagiota Diamantopoulou
    Evangelos Cholongitas
    World Journal of Gastroenterology, 2022, (03) : 310 - 331
  • [49] Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
    Chrysavgis, Lampros
    Giannakodimos, Ilias
    Diamantopoulou, Panagiota
    Cholongitas, Evangelos
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (03) : 310 - 331
  • [50] Hepatocellular Carcinoma Occurence in Non-alcoholic Fatty Liver Disease Without Established Cirrhosis
    Lo, S. T.
    Gane, E.
    Orr, D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : E118 - E119